Company / Debt per Share
PUMA BIOTECHNOLOGY, INC. Debt per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.46
FY2024
5-year range
$0.46 / $2.42
FY2020-FY2024
Trend
-67.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Debt per Share has declined for 3 consecutive years, from $2.42 in FY2021 to $0.46 in FY2024.
Based on SEC 10-K filings.
0.46 in FY2024 with a 5-year CAGR of -28.7%.
Improved from $2.39 to $0.46 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -42.7%
- 5-Year CAGR
- -28.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s debt per share has declined for 3 consecutive years.
- In FY2024, debt per share decreased 67.8% year-over-year.
- Peak debt per share was recorded in FY2018.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.46 | -67.8% |
| FY2023 | $1.42 | -40.7% |
| FY2022 | $2.39 | -1.4% |
| FY2021 | $2.42 | +13.0% |
| FY2020 | $2.14 | -13.5% |
| FY2019 | $2.48 | -38.7% |
| FY2018 | $4.04 | +206.9% |
| FY2017 | $1.32 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026